Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket

Shares of Nxu, Inc. NXU rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors.

Nxu, shares rose 42.1% to $0.0278 in pre-market trading.

Here are some other stocks moving in pre-market trading.


  • XBP Europe Holdings, Inc. XBP shares rose 150% to $14.20 in pre-market trading after declining around 20% on Wednesday.
  • Hanryu Holdings, Inc. HRYU gained 34.8% to $1.47 in pre-market trading after jumping 28% on Wednesday.
  • Meiwu Technology Company Limited WNW shares gained 21.1% to $0.0850 in pre-market trading.
  • Codexis, Inc. CDXS shares surged 20.5% to $2.52 in pre-market trading. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.
  • Esperion Therapeutics, Inc. ESPR shares climbed 15.2% to $1.74 in pre-market trading. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.
  • Blue Water Biotech, Inc. BWV shares rose 14.9% to $0.3109 in pre-market trading after gaining 7% on Wednesday.
  • Ekso Bionics Holdings, Inc. EKSO gained 14.6% to $1.33 in pre-market trading after falling 15% on Wednesday.
  • Nubia Brand International Corp. NUBI rose 13.8% to $11.00 in pre-market trading after falling 9% on Wednesday.
  • Sonoma Pharmaceuticals, Inc. SNOA shares gained 11.1% to $0.19 in pre-market trading.


  • Amtech Systems, Inc. ASYS shares fell 26.4% to $4.41 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
  • Regis Corporation RGS shares fell 22.6% to $7.20 in pre-market trading. NYSE will begin delisting proceedings against Regis Corp.
  • Cepton, Inc. CPTN fell 22.4% to $3.08 in pre-market trading after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast.
  • NextPlay Technologies, Inc. NXTP shares fell 18.4% to $1.28 in pre-market trading after jumping 68% on Wednesday.
  • Ocular Therapeutix, Inc. OCUL shares fell 18% to $3.23 in pre-market trading. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.
  • Applied UV, Inc. AUVI shares fell 14.5% to $1.59 in pre-market trading after declining around 10% on Wednesday. Applied UV teamed with Silver Cross Hospital in New Lenox, Illinois for the implementation of the groundbreaking Far-UVC Puro Protect 222nm fixtures in the hospital's Sterile Processing Department (SPD).
  • Shattuck Labs, Inc. STTK fell 13.5% to $4.20 in pre-market after gaining 130% on Wednesday. Shattuck Labs announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination with Azacitidine (AZA) in frontline high-risk myelodysplastic syndromes (HR-MDS) and TP53 mutant (TP53m) acute myeloid leukemia (AML) patients.
  • Phio Pharmaceuticals Corp. PHIO fell 11.8% to $0.6873 in pre-market trading after declining 9% on Wednesday. Phio Pharmaceuticals recently announced it will exercise warrants for $2.8 million in gross proceeds.
  • Intensity Therapeutics, Inc. INTS shares fell 8.4% to $9.05 in pre-market trading after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.
  • Adobe Inc. ADBE fell 6.1% to $586.38 in pre-market trading. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.


Now Read This: Lennar Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!